ADMA Biologics, Inc. (ADMA) — Dilution Risk Analysis

Current Snapshot

ADMA Biologics, Inc. (ADMA) has a DilutionWatch score of 25/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
223,984,680 Source
Public Float
226,729,341 Source
Float as % of Outstanding
101.2%

Dilution Risk Score

Score: 25/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: FORM 4 1, 4 8, 3 1.

FormFiledAccession
Form 4 2026-07-24 0001140361-26-029923|0002017423|2026-07-24|F|3177
4 2026-07-17 0001140361-26-028844
4 2026-04-03 0001140361-26-013206
4 2026-03-17 0001140361-26-009899
4 2026-03-17 0001140361-26-009900
4 2026-03-10 0001140361-26-008904
4 2026-03-10 0001140361-26-008905
4 2026-03-09 0001140361-26-008363
4 2026-03-02 0001140361-26-007406
3 2026-02-26 0001140361-26-007008

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 999 months Source
Three-year share count growth -0.88% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 25/10) Source
Cash Runway
999 months Source
Share Count Growth (3-Year)
-0.88% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.